COMPASS
A randomized controlled trial of rivaroxaban for the prevention of cardiovascular events in patients with coronary or peripheral artery disease
- Stage
- klaar
- Medicine
- rivaroxaban
- Population
- ASCVD
- Phase
- III
- First Patient In
- 1 January 2013
- Last Patient In
- 9 May 2016
- Last Patient Last Visit
- 28 February 2018
National Lead
dr. A.M.W. Alings
Cardioloog
Study Director
